PMCTPharmaCountry
    Startseite

Regulatorische Updates

Regulatorische Entwicklungen von FDA, EMA, TGA und weltweit

#3573 ×

UPDATED
Regulatorische Updates
10. Sept. 2026•1 Min. Lesezeit
FDA Approves Chartwell Molecular Lamotrigine Tablet ANDA077783
FDA has approved ANDA 077783 for oral lamotrigine tablets (25‑200 mg) submitted by Chartwell Molecular, with multiple labeling submissions cleared.